Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Ministry of Justice:
To ask the Secretary of State for Justice, what information his Department holds on the number and proportion of prisoners that were released under the End of Custody Supervised License scheme who were homeless upon their release from prison.
Answered by Edward Argar - Shadow Secretary of State for Justice
End of Custody Supervised Licence (ECSL) began in October 2023. Analysis of its use will be based on at least one year’s worth of data and published in line with the same approach we take for other statistical releases such as deaths of offenders in the community.
Release under ECSL follows the same planning and arrangements as release at the normal automatic release point and that includes making suitable arrangements for accommodation.
We know that having a safe place to stay helps cut crime which is why we are investing in our transitional accommodation service so prison leavers can have a guaranteed 12 weeks of basic, temporary accommodation to provide a stable base on release.
Prisons and Probation have a statutory duty to refer someone at risk of homelessness to a local authority for assistance and we have worked closely with DLUHC on the design and delivery of their Accommodation for Ex-Offenders scheme.
In 2022/23, 86% of prisoners were accommodated on first night of release, up from 80% in 2019/20.
Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Ministry of Justice:
To ask the Secretary of State for Justice, whether his Department has made an equality impact assessment of the proposal to extend the End of Custody Supervised License scheme to a maximum of 70 days within the women's prison estate.
Answered by Edward Argar - Shadow Secretary of State for Justice
End of Custody Supervised License (ECSL) only operates in the prisons where it is required, and it is currently not operating in the women’s estate. The use of ECSL is under constant review and prior to extending its use in the male estate the impact on the criminal justice system, victims and others was carefully considered.
Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Ministry of Justice:
To ask the Secretary of State for Justice, how many prison (a) officers and (b) staff have been investigated for (i) drug smuggling and (ii) corruption at HMP Parc in each of the last four years.
Answered by Edward Argar - Shadow Secretary of State for Justice
The information requested is not held centrally.
Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Ministry of Justice:
To ask the Secretary of State for Justice, with reference to his Department's press release entitled First Rapid Deployment Cells unveiled to boost prison places, published on 3 March 2023, how many such cells have been built as of 9 May 2024.
Answered by Edward Argar - Shadow Secretary of State for Justice
As part of our commitment to build 20,000 prison places, the largest prison build programme since the Victorian era, we have so far delivered c.730 Rapid Deployment Cells (RDCs) across 13 sites, and we are pushing ahead with hundreds more.
Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Ministry of Justice:
To ask the Secretary of State for Justice, if he will make an assessment of the level of availability of nitazenes in prisons.
Answered by Edward Argar - Shadow Secretary of State for Justice
Since February 2024, all prisoners subject to mandatory drug testing in prisons have been tested for fentanyl, a potent synthetic opioid. We are working closely with our contracted drug testing provider to further improve our capabilities to test prisoners for other synthetic opioids, including nitazenes.
Forensic testing of suspected drug finds was made available to all public sector prisons in April 2023. Our contracted forensic analysis provider has capability to detect synthetic opioids including all fentanyls and nitazenes.
All prisons have a zero-tolerance approach to drugs and we are aware of the threat synthetic drugs present. Our current assessment is that there is a low prevalence of Nitazenes in prison custody. However, we are alert to the risks and continue to monitor this.
Our £100 million investment in tough security measures, such as X-ray body scanners, is helping tackle the supply of illicit drugs into prisons.
To prevent the smuggling of drugs through the mail, we have also invested in next-generation drug trace detection machines. As of March 2024, every public sector prison now has this cutting-edge technology.
Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Ministry of Justice:
To ask the Secretary of State for Justice, whether mandatory random drug testing in prisons includes testing for nitrazenes.
Answered by Edward Argar - Shadow Secretary of State for Justice
Since February 2024, all prisoners subject to mandatory drug testing in prisons have been tested for fentanyl, a potent synthetic opioid. We are working closely with our contracted drug testing provider to further improve our capabilities to test prisoners for other synthetic opioids, including nitazenes.
Forensic testing of suspected drug finds was made available to all public sector prisons in April 2023. Our contracted forensic analysis provider has capability to detect synthetic opioids including all fentanyls and nitazenes.
All prisons have a zero-tolerance approach to drugs and we are aware of the threat synthetic drugs present. Our current assessment is that there is a low prevalence of Nitazenes in prison custody. However, we are alert to the risks and continue to monitor this.
Our £100 million investment in tough security measures, such as X-ray body scanners, is helping tackle the supply of illicit drugs into prisons.
To prevent the smuggling of drugs through the mail, we have also invested in next-generation drug trace detection machines. As of March 2024, every public sector prison now has this cutting-edge technology.
Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Ministry of Justice:
To ask the Secretary of State for Justice, how many incidences of (a) assault and (b) serious assault were committed against prison staff at (i) HMP Long Lartin and (ii) HMP Whitemoor in each of the last four years.
Answered by Edward Argar - Shadow Secretary of State for Justice
We publish the number of assaults and serious assaults against prison staff, broken down by establishment, as part of our Safety in Custody statistics, in Table 8e and 8f of the summary tables, available at the following link:
Totals for those occurring at HMP Long Lartin can be seen at row 94, and for HMP Whitemoor at row 151.
Improving the safety of staff and prisoners is our priority and while overall assault rates remain below pre-pandemic levels, we will continue to protect our hardworking staff through our £100 million security investment that led to X-ray body scanners, airport style security measures and drug dogs.
Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Ministry of Justice:
To ask the Secretary of State for Justice, how many prison officers were deployed on detached duty to (a) HMP Long Lartin and (b) HMP Whitemoor in each of the last four years.
Answered by Edward Argar - Shadow Secretary of State for Justice
Staff are deployed on national detached duty (NDD) as a tactical response to support prisons which require it, to cover staffing shortfalls or to meet other operational requirements. NDD is a vital contingency measure to assist H M Prison & Probation Service to maintain good order and security in prisons
The table below shows the average monthly deployment of full-time equivalent NDD staff to the two prisons between October 2022 and April 2024. HMP Whitemoor is no longer receiving NDD support. Except as shown in the table, no NDD staff were deployed to either site during the past four years.
Date | HMP Whitemoor | HMP Long Lartin |
Oct 2022 | 0 | 13.2 |
Nov 2022 | 0 | 36.25 |
Dec 2022 | 0 | 40.2 |
Jan 2023 | 0 | 40 |
Feb 2023 | 0 | 41 |
Mar 2023 | 0 | 37.4 |
Apr 2023 | 0 | 44.5 |
May 2023 | 0 | 61.6 |
Jun 2023 | 0 | 60.5 |
Jul 2023 | 4.5 | 55.75 |
Aug 2023 | 23.4 | 61.2 |
Sep 2023 | 31.25 | 65.5 |
Oct 2023 | 30 | 64 |
Nov 2023 | 31 | 65.4 |
Dec 2023 | 28.5 | 57 |
Jan 2024 | 27.5 | 46.75 |
Feb 2024 | 23.2 | 32.6 |
Mar 2024 | 13.25 | 27.5 |
Apr 2024 | 7.5 | 27 |
Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Ministry of Justice:
To ask the Secretary of State for Justice, whether his Department have made a risk assessment of prison officer vacancies in the Long Term High Security Estate.
Answered by Edward Argar - Shadow Secretary of State for Justice
We closely monitor staffing levels across the estate via a number of internal governance forums, which assess the vacancy levels for individual prisons and across regions and functions, including the Long Term High Security Estate (LTHSE). Vacancies are one of a number of contributory factors that determine HMPPS' assessment of risk and stability within prisons. We will always ensure that prisons are sufficiently staffed to deliver safe and secure regimes. Where establishments feel that their staffing levels will affect stability or regime, including because of vacancies, there are a number of ways they can maximise the use of their own resource and seek support from other establishments in the short term, through processes managed nationally at Agency level. These include overtime payments and support via Detached Duty staff from other prisons.
We are continuing recruitment activity at all sites with a current or future need, including in the LTHSE. Nationally, we have seen a substantial improvement in the national staffing picture within prisons over the past year. The number of Band 3-5 prison officers increased by 1,634 Full Time Equivalent (FTE) between December 2022 and December 2023, and resignation rates have fallen over the same period. This is the result of significant efforts across the agency, including substantial increases in pay for staff, our first-ever nationwide advertising campaign, incentivized recruitment schemes where we incentivised applicants to relocate to ‘harder-to-staff’ sites, and the Prison Officer Alumni Network, where we have fast-tracked former staff back into the service.
Asked by: Ruth Cadbury (Labour - Brentford and Isleworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what representations she has made to NICE on the availability of Enhertu.
Answered by Andrew Stephenson
The Department meets regularly with the National Institute for Health and Care Excellence (NICE) to discuss a range of issues, including access to medicines. The NICE has recommended Enhertu, also known as trastuzumab deruxtecan and made by Daiichi Sankyo, for use through the Cancer Drugs Fund, for the treatment of HER2-positive metastatic or unresectable breast cancer. It is available to eligible National Health Service patients in England, in line with the NICE’s recommendations.
The NICE is currently evaluating Enhertu for the treatment of HER2-low metastatic or unresectable breast cancer. Following negotiations between NHS England and the company, which concluded without a commercial agreement to make it available at a cost-effective price for the NHS, the NICE published final draft guidance on 5 March 2024, that does not recommend it as an option for this indication. The NICE remains open to further discussions with NHS England and the company, and currently expects to publish final guidance on 15 May 2024.